That study was done with vicriviroc which shuts down all
That study was done with vicriviroc which shuts down all chemokine interactions and all immune response. Which accounts for it's bad side effects and it being stopped from doing anymore trials. It's like maraviroc but worse.
On the other hand leronlimab allows a limited immune response (the difference between small and large molecule CCR5 mabs).
Entry into the cells makes no difference, it's the immune response aided by CCR5 that would need to be curbed.
With 1/3rd of flu deaths being caused by an over-active immune response and inflammation limiting that immune response would certainly save lives. The one thing to be determined would be the appropriate dosage of leronlimab. Most likely a 350mg dose or less would be appropriate to balance immune response.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of AnaptysBio's Investor Engagement AnaptysBio, Inc. (NASDAQ: ANAB), based in San Diego, is recognized in the biotechnology sector for its commitment to advancing immunology therapies. This clinical-stage company focuses on tackling autoimmune disorders and inflammatory diseases through innovative therapeutics. Recently, AnaptysBio's president and CEO, Daniel...
Continue Reading
Truist's Big Second Quarter Reveal Boy, isn't it just the way, you blink, and another quarterly earnings season rolls around. Today, it's Truist Financial Corporation (NYSE: TFC) spilling the beans on their second quarter of 2026. If you have even a passing interest in commercial banking, there's fresh data to chew over. But, let's not beat around the bush—it ain't just...
Continue Reading
RadCred's Innovative Approach to Payday Loans RadCred has made waves in the financial industry with the launch of its AI-driven payday loan service, specifically catering to individuals grappling with bad credit. This groundbreaking platform presents a solution that addresses the financial dilemmas many Americans face when traditional lending avenues are not an option....
Continue Reading
Exciting New Karaoke Feature for NIO Vehicles Stingray, well-known in the music and media industry, is excited to announce its latest partnership with NIO, a leader in smart electric vehicle technology. The launch of Stingray Karaoke in NIO vehicles across Europe is set to change the driving experience into a lively and interactive musical adventure. This feature not only...
Continue Reading
Salient Takeaways from Amplify's Latest Literacy Findings The latest literacy data from Amplify paints a sobering picture of our K–2 readers. Only 57% of these young students are on track to meet fundamental reading benchmarks at this point in the academic year. Let that sink in for a second. What does it say about our efforts as a society? The Effects of the Pandemic...
Continue Reading
